However, although urinary protein excretion after the study period showed a trend of increase in the control group, but a trend of decrease in the cilnidipine group, the difference in these changes was not statistically significant ( Table 4 ).
← all excerpts
L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease.
1
—
—